Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 6.3.2023 | EN | Official Journal of the European Union | C 83/28 |

---

Action brought on 23 January 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)

(Case T-19/23)

(2023/C 83/36)

Language in which the application was lodged: English

Parties

Applicant: Laboratorios Normon, SA (Tres Cantos, Spain) (represented by: I. Gonzalez-Mogena Gonzalez, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Sofar SpA (Trezzano Rosa, Italy)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: European Union word mark NORMOCARE — European Union trade mark No 17 767 294

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 26 October 2022 in Case R 916/2022-1

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO and, if appropriate, Sofar Spa to pay the costs of the present proceedings. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 60(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)